About Immunic (IMUX)
Immunic, Inc., formerly Vital Therapies, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on developing oral therapies for the treatment of chronic inflammatory and autoimmune diseases. The Company is developing three small... Read more
- USD0.73
- USD0.77
- USD0.72
- USD2.11
- -36.50%
- --
- 692.71k
- 1.40M
- 63M
- 0.56
- -42.50%
Stock News
1 hour ago
Cramer calls weak ADP jobs data 'disturbing,' warns about stocks coming into earnings too hot
CNBC
1 hour ago
Car buyers drove sales to a 4-year high to beat tariffs. Now sales are running out of gas.
MarketWatch
1 hour ago
There's a new ETF focused on the AI revolution — and it's backed by a well-known tech analyst
Yahoo
1 hour ago
Trump's tax bill would add $2.4 trillion to the debt, says Congress' budget watchdog
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
